CONTENT PREVIEW
Industry

MBDA builds on Australian MMP partnerships

04 October 2017

MBDA announced the signings of a further five Memorandum of Understanding (MoU) with Australian companies as part of its bid for the Missile Moyen Portee (MMP) system anti-tank guided missile (ATGM) component of the Australian Army’s LAND 400 Ph 2 Combat Reconnaissance Vehicle (CRV) programme.The MBDA MMP ATGM being tested by France's DGA in 2014. (DGA)The MBDA MMP ATGM being tested by France's DGA in 2014. (DGA)

The MoUs have seen the company partner with composite material firm Airspeed, communications and through-life support firm Codan Defence Electronics, training and logistics firm Pennant Australasia, protective packaging firm Trimcast, and manufacturing and engineering firm Hofmann Engineering.

Details of work packages were not disclosed.

The MoUs build on two agreements announced in the recent weeks. On 28 September, the firm announced it had signed a MoU with Victorian electrical and mechanical firm Cablex to support subcontracting opportunities, in addition to wider global supply chain work. Furthermore, MBDA also signed a MoU with Queensland's Ferra Engineering on 20 September. Ferra has experience in guided munitions components, providing wing kits for Joint Direct Attack Munitions-Extended Range (JDAM-ER) guided bombs.

MBDA is competing against Rafael Advanced Defence Systems’ Spike LR II missile, with Rafael also looking to allow Australian firm Varley Group to undertake development, building, and support of the missile for the Australian Defence Force (ADF). The proposed joint venture with Varley would make the company the first licensed manufacturer of the Spike LR II missile outside of Israel.

Want to read more? For analysis on this article and access to all our insight content, please enquire about our subscription options ihs.com/contact



(245 of 404 words)
ADVERTISEMENT

Industry Links

IHS Jane's is not responsible for the content within or linking from Industry Links pages.
ADVERTISEMENT
ADVERTISEMENT